GANX - Gain Therapeutics GAAP EPS of -$0.38 beats by $0.08
- Gain Therapeutics press release ( NASDAQ: GANX ): Q3 GAAP EPS of -$0.38 beats by $0.08 .
- $25.7 Million in Cash and Cash Equivalents and Marketable Securities as of September 30, 2022 Provides Strong Financial Foundation and Extends Cash Runway into Q2 2024
For further details see:
Gain Therapeutics GAAP EPS of -$0.38 beats by $0.08